When.com Web Search

  1. Ads

    related to: camp4 therapeutics corp ipo schedule calendar

Search results

  1. Results From The WOW.Com Content Network
  2. CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic ...

    lite.aol.com/tech/story/0022/20241210/9316780.htm

    CAMBRIDGE, Mass., Dec. 10, 2024 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company developing a pipeline of regRNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels across a range of genetic diseases, today announced the appointments of John Maraganore, Ph.D., and ...

  3. Initial public offering - Wikipedia

    en.wikipedia.org/wiki/Initial_public_offering

    An initial public offering (IPO) or stock launch is a public offering in which shares of a company are sold to institutional investors [1] and usually also to retail (individual) investors. [2] An IPO is typically underwritten by one or more investment banks , who also arrange for the shares to be listed on one or more stock exchanges .

  4. 7 upcoming IPOs to watch in 2024 - AOL

    www.aol.com/finance/7-upcoming-ipos-watch-2024...

    Some 108 companies conducted their IPO in 2023 and raised $19.4 billion, according to Renaissance Capital. Those figures rose markedly from the 2022 doldrums of 71 IPOs and just $7.7 billion raised.

  5. Category:Initial public offerings by year - Wikipedia

    en.wikipedia.org/wiki/Category:Initial_public...

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us

  6. Targanta Therapeutics Corporation - Wikipedia

    en.wikipedia.org/wiki/Targanta_Therapeutics...

    Targanta Therapeutics Corporation was a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company also had operations in Indianapolis , Montreal and Toronto . Targanta completed its initial public offering on October 9, 2007 [ 1 ] and traded on the Nasdaq market under the symbol: TARG.

  7. J&J-backed Rapport Therapeutics seeks about $637 million ...

    www.aol.com/news/j-j-backed-rapport-therapeutics...

    The U.S. IPO market is staging a strong comeback after two dismal years, thanks to a rally in the stock market and growing optimism of a possible interest rate cut this year. Rapport, backed by ...

  8. SoftBank-backed Neumora Therapeutics files paperwork for U.S. IPO

    www.aol.com/news/softbank-backed-neumora...

    The filing comes at a time of renewed investor interest in IPOs following a flurry of deals in the United States and European markets, which have over the last year seen many high-profile startups ...

  9. Celgene - Wikipedia

    en.wikipedia.org/wiki/Celgene

    Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid ( lenalidomide ), which is used in the treatment of multiple myeloma , and also in certain anemias.